| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/21/2007 | US20070142370 Azabicyclooctan-3-one derivatives and use thereof |
| 06/21/2007 | US20070142369 Combination of an H3 antagonist/inverse agonist and an appetite suppressant |
| 06/21/2007 | US20070142368 N4-(2-methoxyethyl)-N6-(5methyl-1H-pyrazol-3-yl)-2-styrylpyrimidine-4,6-diamine; Aurora protein kinase inhibitors; anticarcinogenic agents; antitumor agents; antimetastatic agents; melanoma, lymphoma, leukemia; cancer of the colon, colorectum, breast, lung, kidney, pancreas, kidney, stomach; ovaries |
| 06/21/2007 | US20070142367 Method and medicine for treating gastrointestinal disorder including fecal incontinence |
| 06/21/2007 | US20070142366 Jun N-terminal kinase inhibitors; 1H-pyrrolo[2,3-b]pyridines 3-substituted with a C 5-7 carbocycle and 5-substituted by a 5-member heterocycle; 3-(p-(dimethylamino)phenyl)-5-(2-thiazolyl-1H-pyrrolo[2,3-b]pyridine; neurodegenerative disorders related to apoptosis and/or inflammation |
| 06/21/2007 | US20070142365 HIV integrase inhibitors such as 5-(1,1-Dioxido-1,2-thiazinan-2-yl)-7[5-(4-fluorobenzyl)-1,3,4-oxadiazol-2-yl]-1,6-naphthyridin-8-ol, useful in the inhibition of HIV replication, the prevention and/or treatment of infection by HIV, and in the treatment of AIDS and/or ARC |
| 06/21/2007 | US20070142364 Flumazenil for the Treatment of Cocaine Dependency |
| 06/21/2007 | US20070142363 Novel diazabicyclonene derivatives and use thereof |
| 06/21/2007 | US20070142362 4,5-Dihydro-(1H)-pyrazole derivatives as cannabinoid CB1 receptor modulators |
| 06/21/2007 | US20070142361 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations |
| 06/21/2007 | US20070142360 Hydroxyiminopiperazines administered to animals as analgesics; inhibitors of vanilloid receptors |
| 06/21/2007 | US20070142359 Pyrrolo [2,3-c] pyridine derivatives |
| 06/21/2007 | US20070142358 Pyrrolo [2,3-B] pyridine derivatives |
| 06/21/2007 | US20070142357 Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases |
| 06/21/2007 | US20070142356 Association of a sinus node If curent inhibitor and a calcium inhibitor, and pharmaceutical compositions containing it |
| 06/21/2007 | US20070142355 Association of a sinus node If curent inhibitor and an angiotensin converting enzyme inhibitor, and pharmaceutical compositions containing it |
| 06/21/2007 | US20070142354 Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure |
| 06/21/2007 | US20070142353 such as 2-(3-(aminomethyl)pyrrolidin-1-yl)-4-(4-methoxybenzyl)-7-oxo-4,7-dihydro[1,3]thiazolo[4,5-b]pyridine-6-carboxylic acid, used for treating drug-resistant bacterial infections |
| 06/21/2007 | US20070142352 Pteridinone Derivatives as Modulators of Chemokine Receptor Activity |
| 06/21/2007 | US20070142351 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands |
| 06/21/2007 | US20070142350 Therapeutic uses of derivatives of piperidinyl- and piperazinyl-alkyl carbamates |
| 06/21/2007 | US20070142349 4-arylmorpholin-3-one derivatives, their preparation and therapeutic use thereof |
| 06/21/2007 | US20070142348 Microbicidal, prophylactic and therapeutic effect of ctc-96 on papilloma viruses |
| 06/21/2007 | US20070142347 CHONDROPSIN-CLASS ANTITUMOR V-ATPase INHIBITOR COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF |
| 06/21/2007 | US20070142346 Method of treating breast cancer using 17-AAG or 17-AG or a prodrug of either in combination with a HER2 inhibitor |
| 06/21/2007 | US20070142345 Steroids for cancer treatment |
| 06/21/2007 | US20070142344 fluocinonide or fluocinonide acetonide topical with two or more penetration enhancers |
| 06/21/2007 | US20070142343 Mixture with penetration intensifiers, solvents and emulsifiers |
| 06/21/2007 | US20070142342 Pharmaceutical compounds |
| 06/21/2007 | US20070142341 Use of steroid derivatives for the treatment of angiotensin ll related disease e.g. cardiovascular and proliferative disorders |
| 06/21/2007 | US20070142340 Steroids as agonists for FXR |
| 06/21/2007 | US20070142339 Prevention of arterial restenosis with active vitamin d compounds |
| 06/21/2007 | US20070142338 Tetracycline Derivatives and Methods of Use Thereof |
| 06/21/2007 | US20070142337 Treatment of inflammation and organ dysfunction |
| 06/21/2007 | US20070142336 with phenylgoldtriphenylphospine; for cancers that are resistant to platinum based chemotherapeutic agents |
| 06/21/2007 | US20070142335 e.g. 2-amino-2-methyl-4-{1-methyl-5-[4-(3,4-dimethylphenyl)butanoyl]pyrrol-2-yl}butan-1-ol ; immunology-related disease selected from crohn's disease ulcerative colitis, multiple sclerosis, atopic dermatitis, insulin dependent diabetes mellitus, glomerular nephritis and rejection of a transplanted organ |
| 06/21/2007 | US20070142334 cancer, inflammatory, autoimmune, infectious and viral diseases , destructive bone disorders, proliferative and neurodegenerative disorders; 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine |
| 06/21/2007 | US20070142333 Cycloalkyl inhibitors of potassium channel function |
| 06/21/2007 | US20070142332 Prepared by heating the monosodium salt of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid in crystalline form to 50-120 degrees C. under a pressure of 10-100 kPa for 1-48 hours; bioavailability; treatment of bone diseases and for management of metabolism of calcium |
| 06/21/2007 | US20070142331 Lipophilic anticancer drug compounds, compositions and related methods |
| 06/21/2007 | US20070142329 2-Chloro-N-[2-(2-chloro-phenyl)-ethyl]-5-(6-oxo-1,6-dihydro-pyrazin-3-yl)benzamide, for example; useful in the treatment of IL-1 mediated disorders, including inflammatory diseases such as osteoarthritis and rheumatoid arthritis, allergies, asthma, COPD, cancer |
| 06/21/2007 | US20070142328 Compounds and Uses Thereof |
| 06/21/2007 | US20070142326 Treatment of a condition in a mammal with administration of aminosugar and uses thereof |
| 06/21/2007 | US20070142325 Starch |
| 06/21/2007 | US20070142324 Amphiphilic cyclodextrin derivatives, method for preparation thereof and uses thereof |
| 06/21/2007 | US20070142323 Oligosaccharides, preparation method and use thereof, and pharmaceutical compositions containing same |
| 06/21/2007 | US20070142322 Method of using chitosan to reduce shedding of E. coli from bovines |
| 06/21/2007 | US20070142321 Method for preventing growth of bacteria on contact lenses with eye drops |
| 06/21/2007 | US20070142320 Using water insoluble microparticulate glucans comprising branched beta -(1,3)(1,6) glucan, essentially free of unbranched beta -(1,3)(1,6) glucan and non-glucan components |
| 06/21/2007 | US20070142319 Anxiolytic treatment by inhibition of a polysialyltransferase |
| 06/21/2007 | US20070142318 Compositions, methods and kits for repressing virulence in gram positive bacteria |
| 06/21/2007 | US20070142317 Topical composition for treatment of skin disorders |
| 06/21/2007 | US20070142314 Administering a nucleotide decoy of an ets gene or a chimera decoy of NF-Kappa B with a hydrophillic polymer carrier sheet; aneurysm, Marfan's syndrome, aortic detachment, and plaque rupture |
| 06/21/2007 | US20070142311 Diagnosis of hyperinsulinemia and type II diabetes and protection against same |
| 06/21/2007 | US20070142310 treating Human Immuno-Deficiency Virus (HIV); nucleoside or nucleotide analogues; RNA viral diseases; anticarcinogenic agents treating hematopoetic cancers |
| 06/21/2007 | US20070142309 Synthesis of epirubicin from 13-dihydrodaunorubicine |
| 06/21/2007 | US20070142308 Angiogenesis-affecting compounds and methods for use thereof |
| 06/21/2007 | US20070142307 Hormone replacement therapy; menopause therapy; sexual disorders, vasomotor symptoms, atrophic vaginitis, and osteoporosis. |
| 06/21/2007 | US20070142306 Strontium-based complexes, pharmaceutical compositions and dietetic products |
| 06/21/2007 | US20070142305 Antitumor agents; restenosis; antiarthritic agents; antidiabetic agents; platelet-derived growth factor receptor (PDGF-R) |
| 06/21/2007 | US20070142303 Buffer intracellular reduction and oxidation for the stressed cells in various disease states; beneficial as adjunctive support therapy, multiple chemical sensitivity syndrome, Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Roussy-Levy syndrome, Rosenberg Chutorian syndrome, Korsakoff syndrome |
| 06/21/2007 | US20070142301 inhibit HCV NS3/NS4a serine protease activity; modulate the processing of hepatitis C virus (HCV) polypeptide |
| 06/21/2007 | US20070142297 New uses for amino acid anticonvulsants |
| 06/21/2007 | US20070142296 D-amino acid peptides |
| 06/21/2007 | US20070142291 Methods for treating irritable bowel syndrome |
| 06/21/2007 | US20070142290 Surface-modified serum albumin-metal porphyrin composite, and oxygen infusion solution containing the same |
| 06/21/2007 | US20070142283 Angiogenically effective unit dose of FGF-2 and method of use |
| 06/21/2007 | US20070142270 Aryl Sulfonic Pyridoxines as Antiplatelet Agents |
| 06/21/2007 | US20070142268 Antibacterial compounds having a (pyrrole carboxamide)-(benzamide)-(imidazole carboxamide) motif |
| 06/21/2007 | US20070142266 Combination comprising a P-gp inhibitor and an anti-epileptic drug |
| 06/21/2007 | US20070141949 Aggregate of eyeballs of crustaceans, method for using the same, food containing the same and process for producing the same |
| 06/21/2007 | US20070141707 Sponge toxins |
| 06/21/2007 | US20070141677 Genetic immunization with cationic lipids |
| 06/21/2007 | US20070141669 Pregnancy-associated plasma protein-A2 (PAPP-A2) |
| 06/21/2007 | US20070141631 Methods for testing for and inhibiting the development of Huntington's disease |
| 06/21/2007 | US20070141621 Method Of Screening For Sensitivity To Kinase Inhibitor Therapy |
| 06/21/2007 | US20070141619 Drug resistance-associated gene and use thereof |
| 06/21/2007 | US20070141590 Modulators of tissue regeneration |
| 06/21/2007 | US20070141579 MUM-1 protein expressed by multiple myeloma-related gene |
| 06/21/2007 | US20070141276 Novel 14 and 15 membered ring compounds |
| 06/21/2007 | US20070141221 Edible oils consisting of medium chain triglyceride oils interesterified with long chain domestic oils and phytosterols; cholesterol lowering and metabolic benefits |
| 06/21/2007 | US20070141187 Treating niacin-induced flush by administering a a synergistic mixture of non-bovine sulfated proteoglycan, olive kernel oil, and quercetin or luteolin. |
| 06/21/2007 | US20070141185 Oral microemulsion composition comprising biphenydimethyldicarboxylate and silybin |
| 06/21/2007 | US20070141184 Composition for oral administration containing capsaicinoids |
| 06/21/2007 | US20070141183 tetrahydroisohumulone and dihydro-isohumulone coadministration; antiinflammatory; for treatment of diabetes |
| 06/21/2007 | US20070141182 Combination of multiple nonteroidal antiinflammatory drugs and muscle relaxants for local treatment of musculoskeletal pain |
| 06/21/2007 | US20070141181 Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals |
| 06/21/2007 | US20070141179 Methods for alleviating symptoms associated with menopause using sensory regimen |
| 06/21/2007 | US20070141178 Processes for Obtaining Lignan Extracts and Compositions Containing the Lignan Extracts |
| 06/21/2007 | US20070141176 Elemental sulfur as an oral or parentral medical product |
| 06/21/2007 | US20070141175 Chemotherapy adjuvant |
| 06/21/2007 | US20070141174 An oral formulation of cicletanine with carvedilol, lacidipine, or eplerenone; diabetes, diabetic complications, dyslipidemia, and cardiovascular and metabolic disorders; drug delivering stents |
| 06/21/2007 | US20070141171 Novel composition and method for the treatment of hypertension |
| 06/21/2007 | US20070141170 Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision |
| 06/21/2007 | US20070141169 Homeopathic drug composition and methods of use thereof |
| 06/21/2007 | US20070141167 Use of Benzyl Nicotinate for Pain Relief |
| 06/21/2007 | US20070141165 Method for Manufacturing Microcapsules Containing Capsinoid |
| 06/21/2007 | US20070141162 Injectable compositions for the controlled delivery of pharmacologically active compound |
| 06/21/2007 | US20070141161 Liquid ganaxolone formulations and methods for the making and use thereof |
| 06/21/2007 | US20070141158 Amphiphilic heparin derivative formed by coupling a heparin with a bile acid |